The companies are accelerating the pace of an existing collaboration with the goal of detecting SMA "2+0" carrier status.
AmCare Genomics said that it has a large network that would enable it to raise awareness about Genomic Vision's test for facioscapulohumeral muscular dystrophy.
The growth was driven in part by a strong increase in revenues for the company's life sciences research products.
APG Bio will distribute the products and services to life science researchers in China, Hong Kong, and Macau.
The company attributed the decline to lower revenues from its collaboration with Quest Diagnostics.
Product sales rose nearly 23 percent during the year, but this was offset by a 34 percent dip in revenue from an R&D collaboration with Quest Diagnostics.
The French molecular diagnostics company said almost 95 percent of its revenue during the quarter came from its R&D collaboration with Quest Diagnostics.
The company and the hospital will conduct a clinical study into the detection and prevention of the disease.
Under the arrangement, the partners will use Genomic Vision's molecular combing technology to identify genetic variations underlying different diseases.
A 56 percent increase in revenues from the French molecular diagnostic firm's collaboration with Quest Diagnostics drove up overall revenue growth.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.
Futurism writes that gene doping could be the next generation of cheating in sports.